Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19.
Nurpeisova A, Khairullin B, Abitaev R, Shorayeva K, Jekebekov K, Kalimolda E, Kerimbayev A, Akylbayeva K, Abay Z, Myrzakhmetova B, Nakhanov A, Absatova Z, Nurabayev S, Orynbayev M, Assanzhanova N, Abeuov K, Kutumbetov L, Kassenov M, Abduraimov Y, Zakarya K. Nurpeisova A, et al. Among authors: kerimbayev a. Hum Vaccin Immunother. 2022 Nov 30;18(5):2087412. doi: 10.1080/21645515.2022.2087412. Epub 2022 Aug 12. Hum Vaccin Immunother. 2022. PMID: 35960911 Free PMC article.
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters.
Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L. Zhugunissov K, et al. Among authors: kerimbayev a. Front Microbiol. 2021 Sep 27;12:720437. doi: 10.3389/fmicb.2021.720437. eCollection 2021. Front Microbiol. 2021. PMID: 34646246 Free PMC article.
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up.
Khairullin B, Zakarya K, Orynbayev M, Abduraimov Y, Kassenov M, Sarsenbayeva G, Sultankulova K, Chervyakova O, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Zhugunissov K, Assanzhanova N, Nurabayev S, Kerimbayev A, Yershebulov Z, Burashev Y, Kulmagambetov I, Davlyatshin T, Sergeeva M, Buzitskaya Z, Stukova M, Kutumbetov L. Khairullin B, et al. Among authors: kerimbayev a. EClinicalMedicine. 2022 Jun 25;50:101526. doi: 10.1016/j.eclinm.2022.101526. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35770251 Free PMC article.
Near-Complete Genome Sequence of a SARS-CoV-2 Variant B.1.1.7 Virus Strain Isolated in Kazakhstan.
Usserbayev B, Zakarya K, Kutumbetov L, Orynbaуev M, Sultankulova K, Abduraimov Y, Myrzakhmetova B, Zhugunissov K, Kerimbayev A, Melisbek A, Shirinbekov M, Khaidarov S, Zhunushov A, Burashev Y. Usserbayev B, et al. Among authors: kerimbayev a. Microbiol Resour Announc. 2022 Sep 15;11(9):e0061922. doi: 10.1128/mra.00619-22. Epub 2022 Aug 23. Microbiol Resour Announc. 2022. PMID: 35997492 Free PMC article.
Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan.
Burashev Y, Usserbayev B, Kutumbetov L, Abduraimov Y, Kassenov M, Kerimbayev A, Myrzakhmetova B, Melisbek A, Shirinbekov M, Khaidarov S, Tulman ER. Burashev Y, et al. Among authors: kerimbayev a. Microbiol Resour Announc. 2022 Dec 15;11(12):e0111422. doi: 10.1128/mra.01114-22. Epub 2022 Nov 14. Microbiol Resour Announc. 2022. PMID: 36374112 Free PMC article.
Saigas on the brink: Multidisciplinary analysis of the factors influencing mass mortality events.
Kock RA, Orynbayev M, Robinson S, Zuther S, Singh NJ, Beauvais W, Morgan ER, Kerimbayev A, Khomenko S, Martineau HM, Rystaeva R, Omarova Z, Wolfs S, Hawotte F, Radoux J, Milner-Gulland EJ. Kock RA, et al. Among authors: kerimbayev a. Sci Adv. 2018 Jan 17;4(1):eaao2314. doi: 10.1126/sciadv.aao2314. eCollection 2018 Jan. Sci Adv. 2018. PMID: 29376120 Free PMC article.
Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19.
Shorayeva K, Nakhanov A, Nurpeisova A, Chervyakova O, Jekebekov K, Abay Z, Assanzhanova N, Sadikaliyeva S, Kalimolda E, Terebay A, Moldagulova S, Absatova Z, Tulendibayev A, Kopeyev S, Nakhanova G, Issabek A, Nurabayev S, Kerimbayev A, Kutumbetov L, Abduraimov Y, Kassenov M, Orynbayev M, Zakarya K. Shorayeva K, et al. Among authors: kerimbayev a. Vaccines (Basel). 2023 Nov 28;11(12):1771. doi: 10.3390/vaccines11121771. Vaccines (Basel). 2023. PMID: 38140175 Free PMC article.